PDCD1 and melanoma: Interestingly, if stool samples derived from melanoma patients who positively responded to anti-PD-1 therapy are transplanted into germ-free mice then an amelioration of the antitumor effects of PD-1 blockade occurs, whereas if FMT is performed using stools derived from non-responders then anti-PD-1 failed in its achievement [170].